In this large validation study that included 616 patients with non-metastasis ccRCC from two distinctive medical institutions, we were able to clarify that a high NUCB2 expression level was an independent negative prognostic indicator for CSS. Here, NUCB2 is linked to nonpapillary renal cell carcinoma.